Stroke

Personalized Stroke Rehabilitation Using Delta-alpha Ratio Guided High-definition Tdcs to Enhance Motor Recovery

Tuesday, October 28, 2025

12:30 PM - 12:45 PM

Location: Station 9

Non-presenting author(s)

Beni Mulyana, PhD

Postdoctoral Research Associate
University of Illinois at Urbana Champaign
Joohwan Sung, PhD

Postdoctoral Research Associate
Department of Bioengineering at University of Illinois Urbana-champaign
Mahmood Rajabtabar Darvish

Research Assistant at Neural Engineering and Rehabilitation Laboratory
Department of Bioengineering, University of Illinois Urbana-Champaign
Bethany Flynn, OTR/L, MSOT

Occupational Therapist, Clinical Researcher
Carle Foundation Hospital
Rita Huan-Ting Peng

Research Assistant
University of Illinois Urbana-Champaign
Xiaoxi Chen, M.D. (she/her/hers)

Research Assistant
Department of Bioengineering, University of Illinois Urbana-Champaign
Luka Bryant

Clinical Research Coordinator
Carle Foundation Hospital
Carly Skadden, MPH, CCRP

Clinical Research Manager
Carle Foundation Hospital
Sanjiv Jain, MD, UHM

Physical Medicine and Rehabilitation Physician
Carle Foundation Hospital
RD

Renee Daniels, PTA, MSHA, CBIS

Director Rehabilitation, Wound & Therapy Services
Carle Health
Wael Hassaneen, MB BCh, MSc, PhD

Neurosurgeon
Carle Foundation Hospital
Amrendra Miranpuri, MD

Neurosurgeon
Carle Foundation Hospital

Upon completion, participant will be able to describe the mechanism and potential benefits of High-Definition Transcranial Direct Current Stimulation (HD-tDCS) in stroke rehabilitation.
Upon completion, participant will be able to discuss how the Delta-Alpha Ratio (DAR) topography can guide personalized treatment strategies for motor recovery post-stroke
Upon completion, participant will be able to identify the primary clinical outcome measures used to assess motor impairment and recovery in stroke patients
Upon completion, participant will be able to evaluate the role of DAR as a potential biomarker for stroke rehabilitation outcomes
Upon completion, participant will be able to interpret results from clinical trials investigating the effects of HD-tDCS on cortical modulation and motor function